Insider Transactions Reported by 11 Insiders of NeuBase Therapeutics, Inc.

Location
Pittsburgh, PA

There are no Buy or Sell transactions made by insiders since 19 Mar 2025

NeuBase Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Symetryx Corp 10%+ Owner $369,564 14 Sep 2023
Dietrich A. Stephan Founder and CEO, Director, 10%+ Owner $301,294 02 Aug 2023
Todd P. Branning Chief Financial Officer $161,664 16 Mar 2023
William Roland Mann Chief Operating Officer $21,504 30 Mar 2022
Gerald J. McDougall Director 09 Sep 2022
Kianoush Motesharei Officer 24 May 2021
Sandra Rojas-Caro Chief Medical Officer 24 Jan 2022
Eric I. Richman Director 09 Sep 2022
Franklyn G. Prendergast Director 09 Sep 2022
Eric J. Ende Director 09 Sep 2022
Dov A. Goldstein MD Director 09 Sep 2022

Recent Insider Transactions by Companies or Individuals for NeuBase Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.